Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ee49944d-8571-4c2c-8f60-c95f46ba902d&Preview=1 -
Date
5/16/2012 -
Company Name
Ra Pharmaceuticals -
Mailing Address
One Kendall Square Cambridge, MA 02139 -
Company Description
Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma’s peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability. -
Website
http://www.rapharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,600,000 -
Transaction Round
Series A -
Proceeds Purposes
2nd tranche. We will continue to build out our pipeline using our high-diversity drug discovery platform capable of generating optimized lead candidates in a matter of weeks, but also hope to secure discovery and development partnerships as we gain momentum with our internal programs. -
M&A Terms
-
Venture Investor
New Enterprise Associates -
Venture Investor
Morgenthaler Ventures -
Venture Investor
Novartis Venture Fund -
Venture Investor
Amgen Ventures
